Astec LifeSciences Limited has informed the Exchange regarding allotment of 339 securities pursuant to ESOP/ESPS at its meeting held on May 26, 2025
ASTEC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
On May 26, 2025, the Nomination and Remuneration Committee of Astec LifeSciences approved the allotment of 339 equity shares (face value Rs. 10 each) to an employee upon exercise of stock options under the ESOP 2012 plan. The exercise price was Rs. 10 per option, matching the face value, and the company received Rs. 3,390 in total. With this allotment, the company's total paid-up equity share capital now stands at Rs. 19.61 crore, comprising 1,96,11,710 equity shares of Rs. 10 each. This is a routine disclosure of a small ESOP exercise with no material change to the capital structure.
Negligible dilution of just 339 shares on a base of nearly 1.96 crore shares; routine ESOP exercise with no meaningful impact on shareholders or stock price.